4DMedical Ltd Statistics
Want to see AU:4DX full AI Analyst Report?
4DMedical Ltd (4DX) Stock Statistics & Valuation Metrics
Total Valuation
4DMedical Ltd has a market cap or net worth of AUD 1.42B. The enterprise value is AUD 2.44B.
- Market Cap
- AUD 1.42B
- Enterprise Value
- AUD 2.44B
Share Statistics
4DMedical Ltd has 602,339,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 602,339,500
- Owned by Insiders
- 12.14%
- Owned by Institutions
- 7.11%
Financial Efficiency
4DMedical Ltd’s return on equity (ROE) is -1.20 and return on invested capital (ROIC) is -15.65%.
- Return on Equity (ROE)
- -1.20
- Return on Assets (ROA)
- -0.56
- Return on Invested Capital (ROIC)
- -15.65%
- Return on Capital Employed (ROCE)
- -0.16
- Revenue Per Employee
- 39.01K
- Profits Per Employee
- -1.13M
- Employee Count
- 181
- Asset Turnover
- 0.02
- Inventory Turnover
- 208.18
Valuation Ratios
The current PE Ratio of 4DMedical Ltd is -6.00. 4DMedical Ltd’s PEG ratio is 0.01.
- PE Ratio
- -6.00
- PS Ratio
- 200.87
- PB Ratio
- 8.30
- Price to FCF
- -44.02
- Price to Operating Cash Flow
- -45.17
- PEG Ratio
- 0.01
Income Statement
In the last 12 months, 4DMedical Ltd had revenue of 7.06M and earned -204.44M in profits. Earnings per share was -0.03.
- Revenue
- 7.06M
- Gross Profit
- -38.08M
- Operating Income
- -57.46M
- Pretax Income
- -210.23M
- Net Income
- -204.44M
- EBITDA
- -52.00M
- Earnings Per Share (EPS)
- -0.03
Cash Flow
In the last 12 months, operating cash flow was -31.27M and capital expenditures -949,830, giving a free cash flow of -32.22M billion.
- Operating Cash Flow
- -31.27M
- Free Cash Flow
- -32.22M
- Free Cash Flow per Share
- -0.05
Dividends & Yields
4DMedical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -2.29%
- Earnings Yield
- -14.56%
Stock Price Statistics
- Beta
- 2.25
- 52-Week Price Change
- 43.73%
- 50-Day Moving Average
- 3.64
- 200-Day Moving Average
- 4.05
- Relative Strength Index (RSI)
- 28.88
- Average Volume (3m)
- 4.50M
Important Dates
4DMedical Ltd upcoming earnings date is Feb 26, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Aug 28, 2026
- Next Earnings Date
- Feb 26, 2027
- Ex-Dividend Date
- ―
Financial Position
4DMedical Ltd as a current ratio of 30.79, with Debt / Equity ratio of 1.89%
- Current Ratio
- 30.79
- Quick Ratio
- 30.77
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 5.28
- Interest Coverage Ratio
- -21.08
Taxes
In the past 12 months, 4DMedical Ltd has paid -5.80M in taxes.
- Income Tax
- -5.80M
- Effective Tax Rate
- 0.03
Enterprise Valuation
4DMedical Ltd EV to EBITDA ratio is -21.82, with an EV/FCF ratio of -35.21.
- EV to Sales
- 160.69
- EV to EBITDA
- -21.82
- EV to Free Cash Flow
- -35.21
- EV to Operating Cash Flow
- -36.28
Balance Sheet
4DMedical Ltd has AUD 277.95M in cash and marketable securities with AUD 3.22M in debt, giving a net cash position of AUD 274.74M billion.
- Cash & Marketable Securities
- AUD 277.95M
- Total Debt
- AUD 3.22M
- Net Cash
- AUD 274.74M
- Net Cash Per Share
- AUD 0.46
- Tangible Book Value Per Share
- AUD 0.17
Margins
Gross margin is -539.23%, with operating margin of -813.68%, and net profit margin of -2895.06%.
- Gross Margin
- -539.23%
- Operating Margin
- -813.68%
- Pretax Margin
- -2977.16%
- Net Profit Margin
- -2895.06%
- EBITDA Margin
- -736.40%
- EBIT Margin
- -813.68%
Analyst Forecast
The average price target for 4DMedical Ltd is AUD 4.17, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- AUD 4.17
- Price Target Upside
- 77.30% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 3
- Revenue Growth Forecast
- 20.64%
- EPS Growth Forecast
- -457.40%
Scores
- Smart Score
- 2
- AI Score
- 46
